| Value | ₹2,102 Cr |
|---|
BSE filing, NSE: DALMIASUG. Summary written from the filing by ALFA Finder's alert engine.
Dalmia Bharat Sugar and Industries Ltd: key numbers
- Share price
- ₹420.80
- Market cap
- ₹3,406 Cr
- Revenue (annual)
- ₹3,618 Cr
- Net profit (annual)
- ₹236.7 Cr
- P/E (TTM)
- 16.6×Sector 27.1×
- Promoter holding
- 74.91%+0.00% QoQ
- FII holding
- 0.89%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dalmia Bharat Sugar and Industries Ltd
All →Dalmia Bharat Sugar and Industries Board Meeting Date
Dalmia Bharat Sugar scheduled its board meeting for November 3, 2026 to approve half-year results. No financial figures disclosed in this intimation.
Dalmia Bharat Sugar and Industries Debt & Borrowing: ₹822.5 Cr
EATL, a Dalmia Bharat Sugar subsidiary, secured a $87.5 million CRDB Bank term loan for its Tanzania sugar project. DBSIL sponsors an SBLC on 51% of principal.
- Value
- ₹822.5 Cr
- Execution
- 10 years
- sugar manufacturing capacity
- 3500 TCD
Dalmia Bharat Sugar and Industries Other Announcement
The document presents the quarterly shareholding pattern for Dalmia Bharat Sugar and Industries Ltd as of September 30, 2026, filed under Regulation 31(1)(b).
Dalmia Bharat Sugar and Industries Merger & Restructuring
Dalmia Bharat Sugar incorporated a wholly-owned subsidiary, Dalmia Bharat Global Holdings Limited, in Abu Dhabi. The entity will hold the company's present and future foreign investments.
Dalmia Bharat Sugar and Industries Legal & Regulatory
Dalmia Bharat Sugar received a penalty order of Rs. 1.55 Lakh from the UP-GST authority for e-way bill non-compliance. The company plans to appeal the order.
- Value
- ₹0.02 Cr
Dalmia Bharat Sugar and Industries Other Announcement
Dalmia Bharat Sugar and Industries Limited filed a certificate from its Registrar pursuant to SEBI Regulation 74(5) regarding securities dematerialization for the quarter ended September 30, 2026.
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.